Table 2 Major adverse cardiac events at 5-year follow-up
From: Impact of diabetes mellitus on ischemic cardiomyopathy. Five-year follow-up. REVISION-DM trial
Patients | Group 1 (LVEF ≤ 30) | Group2 (LVEF ≥ 55) | Group3 (LVEF ≥ 55) | Group4 (LVEF ≤ 30) | χ2 |
|---|---|---|---|---|---|
Nonfatal AMI | 12 | 1 | 15 | 6 | 14.11* |
Overall mortality | 49 | 13 | 9 | 24 | 31.48* |
Stroke | 1 | 1 | 2 | 3 | 1.81 |
Intervention | 10 | 25 | 22 | 6 | 22.19* |